Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Chronic Illness

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Chronic Illness in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Long, VP1
Bonilla, IM1
Baine, S1
Glynn, P1
Kumar, S1
Schober, K1
Mowrey, K1
Weiss, R1
Lee, NY1
Mohler, PJ1
Györke, S1
Hund, TJ1
Fedorov, VV1
Carnes, CA1
da Silva Torres, IL1
Bonan, CD1
Crema, L1
De Leon Nunes, M1
Battastini, AM1
Sarkis, JJ1
Dalmaz, C1
Ferreira, MB1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Chronic Illness

ArticleYear
Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated I
    Life sciences, 2020, Jan-01, Volume: 240

    Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Ani

2020
Effect of drugs active at adenosine receptors upon chronic stress-induced hyperalgesia in rats.
    European journal of pharmacology, 2003, Nov-28, Volume: 481, Issue:2-3

    Topics: Adenosine; Animals; Chronic Disease; Hyperalgesia; Male; Pain Measurement; Purinergic P1 Receptor Ag

2003